Cello Health Plc

Cello Health (CLL)

Company name:Cello Health Plc
EPIC:CLLTrading Currency:GBX
Market Sector:AIMPISIN:GB00B0310763
Market Segment:ASX1Share Type:DE
WWW Address:www.cellohealthplc.comDescription:ORD 10P
Industry Sector:MEDIA
 Price Price Change [%] Bid Offer Open High Low Volume
 161.00 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] - - - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 182.74 113.50 0.01 -0.88 4.10 - - -

Cello Health Key Figures

(at previous day's close)
Market Cap.182.74m
Shares In Issue113.50m
Prev. Close161.00
PE Ratio- 
Dividend Yield-%
EPS - basic-0.88p
Dividend PS4.10p
Dividend Cover- 
Cash Flow PS11.22p
Return On Equity (ROE)-1.14%
Operating Margin4.26%
PEG Factor- 
EPS Growth Rate-114.04%
Dividends PS Growth Rate6.49%
Net Debt48.78m
Gross Gearing41.03%
Quick Assets48.22m
Net Working Capital2.65m
Intangibles / Fixed Assets88.42%
Turnover PS146.93p
Pre-Tax Profit PS6.27p
Retained Profit PS-4.44p
Cash PS7.53p
Net Cash PS-32.61p
Net Tangible Asset Value PS *1.30p
Net Asset Value PS72.60p
Spread- (-%) 

Cello Health Balance Sheet


Share Price Performance

Sorry No Data Available

Share Price Chart (5 years)

Cello Health Historic Returns

Sorry No Data Available

Cello Health Key Management Ratios

Cello Health Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio33.88 
PE Ratio- 
Tobin's Q Ratio 1.32 
Tobin's Q Ratio (excl. intangibles)3.01 
Dividend Yield-%
Market-to-Book Ratio2.22 
Price-to-Pre-Tax Profit PS25.69 
Price-to-Retained Profit PS-36.22 
Price-to-Cash Flow PS14.35 
Price-to-Sales PS1.10 
Price-to-Net Tangible Asset Value PS123.47 
Price-to-Cash PS21.38 
Net Working Capital PS2.34 
Price Pct to Working Capital PS68.93%
Earnings Yield-%
Average PE25.11 
Years in average3 
PE to PE average-%

Cello Health Financial Ratios

(Leverage Ratios)
Debt Ratio12.50%
Debt-to-Equity Ratio0.14 
Debt-to-Equity Ratio (excl. Intgbl)7.95 
Debt-to-Equity Market Value0.06 
Net Gearing34.91%
Net Gearing (excl. Intangibles)82.95%
Gross Gearing41.03%
Gross Gearing (excl. Intangibles)97.48%
Gearing Under 1 Year32.61%
Gearing Under 1 Year (excl. Intgbl)77.48%
(Liquidity Ratios)
Net Working Capital to Total Assets1.90%
Current Ratio1.06 
Quick Ratio (Acid Test)1.06 
Liquidity Ratio0.19 
Cash & Equiv/Current Assets17.73%
(Solvency Ratios)
Enterprise Value185.95m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.31 
Total Debt/Sales0.34 
Total Debt/Pre-Tax Profit8.06 
Total Debt57.33m
Total Debt/Net Current Assets21.63%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs8 
Beta (60-Mnth)Beta (36-Mnth)

Cello Health Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)7.55%
Return On Assets (ROA)-0.68%
Net Profit Margin-0.57%
Assets Turnover1.20 
Return On Equity (ROE)-1.14%
Return On Investment (ROI)-1.01%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-3.03%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.97 
Fixed Assets Turnover1.97 
Current Assets Turnover3.09 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales0.83 
Debt Collection Period97.44Days

Cello Health Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
18 Mar 2020FinalGBX2.9531/12/201831/12/201923/04/202024/04/202022/05/20204.10
18 Sep 2019InterimGBX1.1531/12/201831/12/201903/10/201904/10/201901/11/2019-
21 Mar 2019FinalGBX2.7531/12/201731/12/201825/04/201926/04/201924/05/20193.85
19 Sep 2018InterimGBX1.1031/12/201731/12/201804/10/201805/10/201802/11/2018-
22 Mar 2018FinalGBX2.4531/12/201631/12/201703/05/201804/05/201825/05/20183.50
20 Sep 2017InterimGBX1.0531/12/201631/12/201705/10/201706/10/201703/11/2017-
22 Mar 2017FinalGBX2.4031/12/201531/12/201604/05/201705/05/201726/05/20173.40
14 Sep 2016InterimGBX1.0031/12/201531/12/201606/10/201607/10/201604/11/2016-
17 Mar 2016FinalGBX2.0231/12/201431/12/201505/05/201606/05/201627/05/20162.86
16 Sep 2015InterimGBX0.8431/12/201431/12/201521/10/201522/10/201527/11/2015-
19 Mar 2015FinalGBX1.8031/12/201331/12/201430/04/201501/05/201529/05/20152.60
17 Sep 2014InterimGBX0.8031/12/201331/12/201401/10/201403/10/201407/11/2014-
20 Mar 2014FinalGBX1.6131/12/201231/12/201304/06/201406/06/201404/07/20142.25
18 Sep 2013InterimGBX0.6431/12/201231/12/201304/12/201306/12/201306/01/2014-
13 Mar 2013FinalGBX1.4231/12/201131/12/201229/05/201331/05/201305/07/20132.00
19 Sep 2012InterimGBX0.5831/12/201131/12/201207/12/201209/12/201204/01/2013-
13 Mar 2012FinalGBX1.1731/12/201031/12/201106/06/201208/06/201206/07/20121.72
13 Sep 2011InterimGBX0.5531/12/201031/12/201107/12/201109/12/201106/01/2012-
15 Mar 2011FinalGBX0.9031/12/200931/12/201008/06/201110/06/201108/07/20111.43
14 Sep 2010InterimGBX0.5331/12/200931/12/201006/10/201008/10/201003/11/2010-
16 Mar 2010FinalGBX0.8031/12/200831/12/200919/05/201021/05/201016/06/20101.30
15 Sep 2009InterimGBX0.5030/06/200830/06/200907/10/200909/10/200904/11/2009-
17 Mar 2009FinalGBX0.7531/12/200731/12/200820/05/200922/05/200917/06/20091.25
16 Sep 2008InterimGBX0.5030/06/200730/06/200808/10/200810/10/200805/11/2008-
23 Mar 2008FinalGBX0.7531/12/200631/12/200721/05/200823/05/200818/06/20081.20
20 Mar 2007FinalGBX0.6031/12/200531/12/200623/05/200725/05/200715/06/20071.00
05 Sep 2006InterimGBX0.4030/12/200530/06/200620/09/200622/09/200613/10/2006-

Cello Health Fundamentals

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
pre tax profit-1.69-1.02%5.823.44%8.425.08%7.114.26%m
attributable profit-2.83-1.71%4.232.50%6.624.00%-0.94-0.57%m
retained profit-5.42-3.28%0.650.39%2.901.75%-5.05-3.03%m
eps - basic (p)-3.23 4.09 6.27 -0.88 
eps - diluted (p)-3.23 4.03 6.14 -0.88 
dividends per share3.40 3.50 3.85 4.10 

Cello Health Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
fixed assets fixed assets2.712.11%2.841.95%2.932.13%2.651.89%m
intangibles intangibles70.5354.97%74.1550.92%75.0154.46%80.9257.91%m
fixed investments fixed investments--%--%--%7.955.69%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors47.6037.10%55.6038.19%49.3735.84%39.6728.39%m
cash & securities cash & securities7.475.82%13.028.94%10.427.57%8.556.12%m
creditors - short creditors - short49.1938.34%49.8934.26%45.4032.96%45.5732.61%m
creditors - long creditors - long12.569.79%12.858.82%5.514.00%11.778.42%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves66.5551.87%82.8756.92%86.8363.04%82.4058.97%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Cello Health Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
Operating CF4.852.7311.1812.73m
Pre-Financing CF2.59-4.378.985.92m
Retained CF1.765.87-2.75-1.84m

Cello Health Brokers

Altium Capital LimitedMarket Maker(MMF)Broker/DealerALTIAPCFGB21
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
Cello Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20221130 19:53:41